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Abstract: A promising approach to improve the poor antibacterial properties of dental composite
resins has been the addition of metal oxide nanoparticles into the resin matrix. This systematic
review aimed to determine whether the addition of zinc oxide nanoparticles (ZnO-NPs) improves the
antibacterial properties of direct dental composite resins. This review was conducted in accordance
with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines
and registered with the PROSPERO database: CRD42019131383. A systematic literature search was
conducted using the following databases: Medline (Ovid), the Cochrane Library, SCOPUS, CINAHL,
Web of Science, Trove, Google Scholar, World Cat, and OpenGrey. The initial search retrieved 3178
results, which were then screened against inclusion and exclusion criteria, resulting in a total of
four studies that were eligible for qualitative synthesis within this review. All the included studies
were in vitro non-randomized post-test design experimental studies. A lack of congruity in the
results obtained from these studies that used different tests to evaluate antibacterial activity was
evident. Although some studies demonstrated a significant improvement of antibacterial properties
in composites containing at least 1% ZnO-NPs (wt %), they are unlikely to present any clear clinical
advantage due to the short lifetime of observed antibacterial properties.
Keywords: antibacterial agents; composite resin; zinc oxide; nanoparticles; zinc oxide nanoparticles;
dentistry; dental materials; systematic review
1. Introduction
Dental caries is a widespread infectious disease, in which the hard tooth structure is
demineralized as a result of the acid produced by the bacterial fermentation of carbohy-
drates. Various direct restorative materials have been used to restore (fill) these carious
defects ranging from metallic fillings (silver amalgam, direct gold) to cements (silicates,
phosphates, glass-ionomer) and polymer resin/inorganic filler-based composite resins [1,2].
Composite resins are widely used and have predominantly replaced amalgam restorations
due to their superior aesthetics and bonding ability in restorative procedures [2,3]. How-
ever, some in vitro and in vivo studies have reported that composite resin surfaces, due
to its surface roughness, tend to harbor more bacterial plaque when compared with other
restorative materials such as silver amalgam, glass ionomer cements (GIC), and also dental
hard tissues such as enamel [4–7]. Other technique-related factors that can significantly
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affect the longevity of composite resin restorations include the adhesive system and etch-
ing agent used [3,8,9]. Composite resin materials are known to undergo polymerization
shrinkage at margins, making them susceptible to secondary caries and eventually failure
of the restoration [10]. Therefore, the development of dental composites that can resist
plaque accumulation and as a result decrease bacterial acid-induced demineralization
could increase the longevity of direct dental composite resin restorations [11]. A significant
amount of research has been conducted on the incorporation of antibacterial agents into
direct dental composite resins. Examples of these agents include fluoride, chlorhexidine,
quaternary ammonium, and metal oxide particles/ions such as silver, gold, titanium, and
zinc [12–17].
One promising approach has been the addition of metal oxide nanoparticles into the
resin matrix [18]. As the antibacterial activity of metal oxides is dependent on the total
contact surface area, the incorporation of nanoparticulate (1–100 nm) metal oxides allows
for superior antibacterial properties, as the surface to volume ratio increases exponentially
with decreasing particle size [19,20]. Similarly, silver nanoparticles have been incorporated
as antibacterial agents without causing significant detrimental changes to the mechanical
properties of dental composites [21]. However, the inclusion of silver causes discoloration of
the composite, which is not favorable for aesthetic restorations, restricting its use primarily
to restorations on posterior teeth [22].
Traditionally, nanofilled composites are known to allow for desired polishing results
and are hence widely used for direct anterior restorations with an acceptable clinical
longevity [23,24]. Furthermore, an insoluble, white, or colorless particle with long-lasting
antimicrobial properties are the ideal characteristics of an antibacterial filler to be used
in a direct dental composite resin [18]. Zinc oxide nanoparticles (ZnO-NPs) have these
characteristics, and when incorporated into dental composite resins, they display strong
antibacterial properties [19,25]. Therefore, this systematic review was conducted to evaluate
the current literature on the addition of zinc oxide nanoparticles and establish if these
additives improve the antibacterial properties of direct dental composite resins.
2. Materials and Methods
2.1. Protocol and Registration
This systematic review was conducted in accordance with the guidelines of the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [26]
and was registered with PROSPERO (registration no. CRD42019131383) [27].
2.2. Eligibility Criteria
The articles considered for inclusion were in vitro, in vivo, and ex vivo experimental
studies. The inclusion criteria were as follows: (a) includes zinc oxide nanoparticles incorpo-
rated into direct dental composite resins; (b) investigates the antibacterial properties of direct
dental composite resins incorporating zinc oxide nanoparticles; and (c) does not investigate
only the synergistic antibacterial effects of multiple agents when zinc oxide nanoparticles
are included along with other antibacterial agent(s) in direct dental composite resins.
Exclusion criteria were as follows: (a) articles not published in the English language;
(b) articles for which the full text was inaccessible; (c) case series, case reports, conference
articles/proceedings, book chapters, theses, dissertations, reviews, ideas, editorials, and
opinions.
2.3. Information Sources
An electronic search was carried out into the following bibliographic databases and
gray literature databases: Medline (Ovid); The Cochrane Library (the Cochrane Database of
Systematic Reviews, the Cochrane Central Register of Controlled Trials, and the Cochrane
Methodology Register); Scopus; CINAHL; Web of Science; Trove; Google Scholar; World
Cat; and OpenGrey. There were no restrictions on publication date, language, or study
type in the search.
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2.4. Focus Question
The following focus question was based on the PICO (Problem, Intervention, Compar-
ison, Outcomes) schema [28] and used to guide the search strategy: “Do direct dental resin
composites containing zinc oxide nanoparticles have better antibacterial properties than
conventional dental resin composites?”.
2.5. Search Strategy
The articles were searched and retrieved using different combinations of medical
subject headings (MeSH) terms/subject headings and natural language terms/phrases
which in all instances encompassed the following integral concepts of the focus question:
(a) antibacterial activity, (b) direct dental composite resin, and (c) zinc oxide nanoparticles.
No limits on year of publication were placed for the database searched, and the last
search was conducted in May 2020. The combinations and permutations of search terms
used were optimized for each database according to the functionality of each database.
The following limits determined the optimized search strategy for each database: (a) the
number of retrieved articles after completion of the initial search must be less than the
maximum number of articles retrievable by the database; (b) search syntax variations for
each database; and (c) character limits of the database (Table 1).
Table 1. Search strategy for databases searched.
Database(s) MeSH Terms/Subject Headings and/or Keyword Search
Medline (Ovid)
exp Antibacterial Agents/
(bacteriostatic or bacteristatic or bactericidal* or bacteriocidal* or anti-bacterial or antibacterial or












3 and 6 and 9 and 12
Cochrane Library
(antibacterial OR anti-bacterial OR bactericidal OR bacteriocidal OR bacteriostatic OR bacteriostatic OR
anti-microbial OR antimicrobial) in All Text AND composite in All Text AND (Zinc-Oxide OR “Zinc Oxide”
OR ZnO OR ZnO-NP OR Nano-ZnO OR “Nano zinc oxide” OR Nano-zinc-oxide) in All Text AND
(nanoparticle OR nano-particle) in All Text—(Word variation have been searched)
SCOPUS
(TITLE-ABS-KEY (zno OR “zinc oxide” OR zinc-oxide OR zno-np OR “Nano ZnO” OR nano-zno OR “Nano
zinc oxide” OR nano-zinc-oxide) AND TITLE-ABS-KEY (composite) AND TITLE-ABS-KEY (antibacterial
OR bacteriostatic OR bacteriocidal OR anti-microbial* OR antimicrobial* OR anti-bacterial* OR bactericidal*
OR bacteristatic) AND TITLE-ABS-KEY (nanoparticle* OR nano-particle*))
CINAHL
(ZnO OR “zinc oxide” OR Zinc-Oxide OR ZnO-NP OR “Nano ZnO
OR Nano-ZnO OR “Nano zinc oxide” OR Nano-zinc-oxide) AND composite* AND ((Antibacterial OR
bacteriostatic OR bacteriocidal OR anti-microbial* OR antimicrobial* OR Anti-bacterial OR Bactericidal* OR
bacteristatic)) AND ((nanoparticle* OR nano-particle))
Web of Science
TS = (Antibacterial OR Anti-bacterial OR Bactericidal* OR Bacteriostatic OR Bacteristatic OR Anti-microbial*
OR Antimicrobial*)
TS = (Composite*)
TS = (Zinc-Oxide OR “Zinc Oxide” OR ZnO OR ZnO-NP OR “Nano ZnO” OR Nano-ZnO OR “Nano zinc
oxide” OR Nano-zinc-oxide)
TS = (Nanoparticle* OR Nano-particle*)
#4 AND #3 AND #2 AND #1
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Table 1. Cont.
Database(s) MeSH Terms/Subject Headings and/or Keyword Search
Trove
(ZnO OR “zinc oxide” OR Zinc-Oxide OR ZnO-NP OR “Nano ZnO
OR Nano-ZnO OR “Nano zinc oxide” OR Nano-zinc-oxide) AND composite* AND ((Antibacterial OR
bacteriostatic OR bacteriocidal OR anti-microbial* OR antimicrobial* OR Anti-bacterial OR Bactericidal* OR
bacteristatic)) AND ((nanoparticle* OR nano-particle))
N.B. Search was carried out in the Journals, articles and data sets tab
Google Scholar Dental resin composite antibacterial inhibit biofilm nanoparticle “zinc oxide”
World Cat Dental resin composite antibacterial nanoparticle “zinc oxide”
OpenGrey
(ZnO OR “zinc oxide” OR Zinc-Oxide OR ZnO-NP OR “Nano ZnO
OR Nano-ZnO OR “Nano zinc oxide” OR Nano-zinc-oxide) AND composite* AND ((Antibacterial OR
bacteriostatic OR bacteriocidal OR anti-microbial* OR antimicrobial* OR Anti-bacterial OR Bactericidal* OR
bacteristatic)) AND ((nanoparticle* OR nano-particle))
2.6. Study Selection
The titles and/or abstracts of the articles retrieved were independently screened by
two reviewers to identify articles that potentially met the eligibility criteria. Articles that
definitively did not meet inclusion criteria and/or fulfilled exclusion criteria at this stage
were eliminated. Any disagreements between the two review authors with regard to the
eligibility of any particular article were resolved by consultation with a third reviewer until
an agreement was reached.
For articles that passed this process, the full-text manuscripts were catalogued and
independently assessed by four reviewers for eligibility as per the eligibility criteria.
2.7. Data Collection Process
Data from the full-text manuscripts of the articles identified as eligible for the review
were extracted independently by two reviewers according to the data items listed in below.
Any discrepancies or uncertainties in the data were resolved through discussion with a
third review author until an agreement was reached.
2.8. Data Items
The data relevant to the research question was extracted from the included studies
and tabulated into the following fields for qualitative synthesis:
• Author (year)—presents the author(s) of the article and the year of publication
• Sample—describes the study sample (i.e., type of composite resin)
• Treatment group—describes the treatment group(s), including the average size of zinc
oxide nanoparticles used
• Experiment—names the test conducted (N.B: only data for the tests that assessed the
antibacterial properties of the ZnO-NP composites were included and tabulated)
• Methodology—describes pertinent information on the corresponding test and the
variable(s) measured
• Outcome—describes the outcome(s) of the experiment(s). All outcomes presented are
statistically significant unless specified otherwise.
2.9. Quality and Risk of Bias in Individual Studies
The quality and risk of bias assessments were performed independently by two review
authors using a modified version of the Methodological Index for Non-Randomized Studies
(MINORS) tool (Table 2) [29]. Any disagreements or uncertainties were resolved through
discussion with a third review author until an agreement was reached.
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Table 2. Modified Methodological Index for Non-Randomized Studies (MINORS) tool.
Methodological Items for Non-Randomized Studies (Modified Version) Score *
• A clearly stated aim: the question addressed should be precise and relevant in the light of available literature.
• All samples accounted for: all prepared samples should be accounted for and used as specified in the methods.
• Prospective collection of data: data were collected according to a protocol established before the beginning of
the study.
• Endpoints appropriate to the aim of the study: unambiguous explanation of the criteria used to evaluate the
main outcome, which should be in accordance with the question addressed by the study. In addition, the
endpoints should be assessed on an intention-to-treat basis.
• Unbiased assessment of the study endpoint: there should be a blinding of test operators. In addition, operator
variation in measurement should be taken into account where appropriate.
• Follow-up period appropriate to the aim of the study: the follow-up should be sufficiently long to allow the
assessment of the main endpoint and possible adverse events.
• Results of all tests discussed: results of all tests done should be presented and discussed.
• Prospective calculation of the study size: information of the size of detectable difference of interest with a
calculation of 95% confidence interval, according to the expected incidence of the outcome event, and
information about the level for statistical significance and estimates of power when comparing the outcomes.
• An appropriate control group: an appropriate control group must be present.
• Contemporary groups: control and treatment groups should be managed during the same time period using the
same batch of antibacterial strains/solutions (no historical comparison).
• Baseline equivalence of groups: control samples must be created using the same procedure as non-control
groups, except for steps required for addition of antibacterial agent(s). Absence of confounding factors that
could bias the interpretation of the results.
• Adequate statistical analyses: whether the statistics were in accordance with the type of study with calculation of
confidence intervals or relative risk.
* The items were scored 0 (not reported—high risk of bias), 1 (reported but inadequate—medium risk of bias) or 2 (reported and
adequate—low risk of bias). The global ideal score being 16 for non-comparative studies and 24 for comparative studies.
3. Results
3.1. Study Selection
The initial electronic search of the various databases yielded 3178 results. After
the removal of duplicates, independent screening of titles and/or abstracts, five studies
remained for assessment of eligibility based on full-text review. One study by Shen et al.
(2016) was excluded from the review as nanoparticulate zinc oxide was not used in this
study [30]. A total of four studies met the all the eligibility criteria and are included in this
systematic review (Figure 1).
3.2. Study Characteristics
All of the four studies included in this review were non-randomized in vitro experi-
mental studies. The data extracted from the included studies are presented in Table 3.
Three of the studies included in this review investigated the antibacterial properties
of ZnO-NP composite resins via a direct contact test where the variable of viable colony-
forming units (CFUs) was measured [11,25]. In the studies by Hojati et al. and Kasraei
et al., it was reported that the composite resin discs containing at least 1 wt % ZnO-NPs had
a statistically significant reduction in the number of CFUs [11,25]. However, Sevinç et al.
noted no statistically significant difference in the 1% ZnO-NP composite resins compared
to the unmodified control [25]. Nevertheless, all three studies reported a reduction in the
number of CFUs with higher concentrations of ZnO-NPs, with the notable exception of the
three-species biofilm direct contact test by Sevinç et al. In this test, a three species bacterial
inoculum of S. oralis, S. gordonii, and A. naeslundii was used with a 10 wt % ZnO-NP
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composite resin. The authors found no statistically significant reduction in the number of
CFUs between the 10 wt % ZnO-NP composite resin and the control [25].
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3.3. Quality and Risk of Bias Assessment
The quality and risk of bias assessments for the four articles included in the re-
view were carried out using the modified version of the Methodological Index for Non-
Randomized Studies (MINORS) tool [29] and are summarized in Figure 2 and Table 4. The
primary sources of bias in the four articles are the absence of operator blinding, the lack
of publication of the study protocol prior to conducting the study, and the absence of a
prospective calculation of the study sample size required. Hence, all studies scored 1 for
item three and 0 for items five and eight in the modified MINORS tool. Overall, all articles
scored between 18 and 19 points in total, hence, presenting with a moderate risk of bias.
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Table 3. Summary of studies included in this systematic review.
Author








1, 5, and 10 wt % uncoated
ZnO-NPs (40–100 nm) in
microhybrid composite resin
1 wt % polar coated ZnO-NPs
(40–100 nm) in microhybrid
composite resin
1 wt % non-polar coated ZnO-NPs
(40–100 nm) in microhybrid
composite resin




(CFUs) after 48 h. S. sobrinus
biofilm.
Reduced CFUs in 5 and 10 wt % ZnO-NP
composites compared to controls.
Aged direct contact test
Viable CFUs after each cycle.
Three cycles of 72 h growth of
S. sobrinus biofilms.
Reduced biofilm growth in the 3rd cycle
for 10 wt % ZnO-NP composite compared




Viable CFUs after 72 h of biofilm
growth. Bacterial culture of
S. oralis, S. gordonii, and
A. naeslundii was used.
No statistically significant reduction in
CFUs between 10 wt % ZnO-NP







composite discs via scanning
electron microscopy and confocal
laser microscopy. Age of
S. sobrinus biofilm was 24 h.
S. Sobrinus attachment and biofilm
coverage was qualitatively lower on the
10 wt % ZnO-NP composites compared to
unmodified control composites in both
SEM and CLSM. Both SEM and CLSM
visualization revealed qualitatively less
dense biofilm formation and greater space
between microbes in the 10 wt % ZnO-NP
composite compared to the control.
Kinetic measurement of
bacterial growth
Well suspension culture plates
were coated with composite
resins and inoculated with
bacterial culture for 6 h. The per
hour absorbance measurements
were recorded using a plate
reader (490 nm at 1 h intervals for
12 h).
There was no statistically significant
difference between the 1, 5, and 10 wt %
ZnO-NP composites at the 14th h.
However, all of these composites showed a
reduction in absorbance measurements
compared to the control composites.
Agar diffusion test
The inhibition zones around the
composite discs were measured
after 48 h incubation of bacteria
inoculated BHI agar plates.
There was no zone of inhibition around
either the ZnO-NP composites or the
unmodified composites. In addition,
bacterial colonies were observed on the
bottom surfaces of these composites.
Materials 2021, 14, 40 8 of 15
Table 3. Cont.
Author





1, 2, 3, 4 and 5 wt % ZnO-NPs
(20 nm) in flowable composite resin
Direct contact test
Visual counting of number of
viable CFUs after 24 h incubation.
Age of the S. Mutans biofilms
were 3, 6, 12, and 24 h.
There was a reduction in the number of
CFUs with an increasing percentage of
ZnO-NPs in all of the ZnO-NP composites
compared to control. The 4 and 5 wt %
ZnO-NP composites completely inhibited
bacterial colony formation.
Aged direct contact test
Visual counting of number of
viable CFUs after 3, 6, 12, and
24 h. All samples were incubated
for 24 h. All samples were
pre-aged with
phosphate-buffered saline (PBS)
for 48 h, 1 week, and 4 weeks.
In 48 h aged samples, there was a
reduction in CFUs in 1, 2, 3, 4, and 5 wt %
ZnO-NP composites compared to the
control. However, there was no
statistically significant difference between
the 1, 2, 3, 4, and 5 wt % ZnO-NP
composites. In the 1-week and 4-week
aged samples, there was no statistically
significant difference between the 1, 2, 3, 4,
and 5 wt % ZnO-NP composites and
the control.
Agar diffusion test
The inhibition zones around the
composite discs were measured
after 24 h incubation of bacteria
inoculated BHI agar plates.
There were no inhibition zones around any
of the composite resin discs containing






visualized samples of composite
discs via SEM. Age of S. Mutans
biofilms were 1 h and 24 h.
For 1 h incubated samples, there was a
qualitatively lower number of and smaller
bacterial colonies in composite resins
containing higher concentration of
ZnO-NPs (3, 4 and 5 wt %) compared to
the composite resins containing a lower
concentration of ZnO-NPs (0, 1, and
2 wt %). The results were similar for
samples incubated for 24 h.
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Table 3. Cont.
Author






1 wt % ZnO-NPs (50 nm) in
flowable composite resin Direct contact test
Visual counting of number of
viable CFUs after 48 h. Age of
S. Mutans or Lactobacillus biofilms
were 12 h for both.
There was a reduction in CFUs of in both
the S. mutans and Lactobacillus groups, for







(BisGMA 70 wt % and
TEGDMA 30 wt %; 70%
barium borosilicate
glass filler)
0.5, 1, 2, 5, and 10 wt % ZnO-NPs
(40–100 nm) in model
composite resin.
Evaluation of metabolic





Based on the enzymatic
reduction of yellow tetrazolium
into purple formazan.
Absorbance values of samples
were recorded using a microplate
reader (540 nm). Age of
S. Mutans biofilm was 72 h.
One, 2, 5, and 10 wt % ZnO-NP composites
decreased the metabolic activity of the
S. mutans biofilm compared to the control.
The 0.5 wt % ZnO-NP composite did not
show a statistically significant difference
compared to the control.
Lactic acid production
Lactic acid analysis of 3 h
incubated samples via the use of
a lactate dehydrogenase (LDH)
reaction (measured in µM). Age
of S. mutans biofilm was 72 h.
Only 5 and 10 wt % ZnO-NP composites
reduced the production of lactic acid by





visualized samples of composite
discs via SEM (5000×
magnification).
A qualitative decrease in the number of
bacterial colonies was noted in the 1, 2, 5,
and 10 wt % ZnO-NP composites
compared to control. There was a
significant decrease in the number of
colonies as ZnO-NP
concentration increased.
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t
S Item Total
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4. Discussion
uch research has been carrie out on the addition of antibacterial agents into direct
dental co posite resins t i r e t eir a ti acterial r erties [12–17]. r isi
approach to achieve this has been the incorporation of metal oxide anoparticles, such
as zinc oxide, as a filler into the resin matrix. A Cochrane review, updated in 2013, by
P reira-Cenci e al. attempted to assess the state of the r search on antibacterial ts
incorporated i t co posite resins, limit ng the scope of their revi w to only ran-
domized controlled trials. They were unable to find any studies that met this cr terion [33].
However, th pres nt systematic review did not place any limitations on study design and
focused exclusively on the addition of zinc oxide nanoparticles as an antibacterial agent,
and hence yielded four studies that were eligible for inclusion in this review. Nevertheless,
similar to the findings of Pereira-Cenci et al., no randomized controlled trials were found;
all of the studies included in this review are in vitro non-randomized post-test design
experimental studies. The rationale for this systematic review was to evaluate the evidence
that the addition of zinc oxide nanoparticles to composite restorative resins improves the
antibacterial properties of direct dental composite resins.
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Overall, there was a lack of congruity in the findings of the studies between the differ-
ent tests/methodologies used to evaluate the antibacterial activity of ZnO-NP composite
resins at lower weight percentage ZnO-NP loadings. Two studies included in this sys-
tematic review reported a significant improvement of antibacterial activity in composite
resins containing at least 1 wt % ZnO-NPs, compared to the controls, in short-term direct
contact tests utilizing a single species biofilm [19,31]; another study had similar findings in
composite resins containing at least 2 wt % ZnO-NPs [25].
In all of the three studies that assessed samples under electron microscopy, a quali-
tative reduction in the number of bacterial colonies was found with increasing ZnO-NP
concentrations; however, the concentrations at which these changes were observed dif-
fered considerably amongst the three studies—1 wt % being the lowest effective loading
depending on the study [19,25,32]. One of the studies measured biofilm metabolic activity
and lactic acid formation, and it came to the conclusion that composites containing at
least 1 wt % ZnO-NP reduce biofilm metabolic activity, but that a decrease in lactic acid
production is only seen at concentrations of 5 wt % ZnO-NPs or greater [32].
Three studies that investigated the antibacterial properties used a direct contact test
followed by viable colony-forming units (CFUs) measurement reported variable results,
specifically in relation to composite resins containing a lower concentration of ZnO-
NPs [19,25,31]. Notable reasons were differences in the direct contact test used; only
Sevinç et al. used an S. sobrinus biofilm, whereas the other two studies used a S. mutans or
Lactobacillus biofilm [25]. In addition, the age of the biofilms used differed among the three
studies, with the S. sobrinus biofilm of Sevinç et al. being at least 48 h more mature than
those used in the other two studies.
In the literature, some studies suggest that ZnO-NP composites may have little antibac-
terial effect against multi-species biofilms [25]. In regard to the findings of the three species
biofilm direct contact test reported by Sevinç et al., the differences may have been due to
the stronger antibacterial resistance of multi-species bacterial biofilms or the species of
bacterium themselves [34]. This may suggest that in a clinical situation, ZnO-NP composite
resins may not provide any benefit over regular dental composites.
Based on experiments that attempted to simulate the aging of composite restorations,
the literature suggests that the antibacterial effect of the ZnO-NP composites may not
be long-lasting [19,25]. Of the studies included in this review, only Sevinç et al. and
Hojati et al. attempted to simulate the effect of restoration aging on the antibacterial
properties of the composite resin samples [19,25]. The methodologies used by the two
studies were considerably different from one another; Sevinç et al. aged their composite
resin samples by subjecting the samples to three cycles of 72 h of biofilm growth, whereas
Hojati et al. aged their samples by subjecting them to a phosphate-buffered saline bath
for 2–28 days [19,25]. Sevinç et al. found no diminishing of antibacterial activity in the
10 wt % ZnO-NP composite resins after the first and second cycle of growth but did note
a statistically significant reduction in antibacterial activity by way of increased CFUs in
the third cycle of growth [25]. Nevertheless, in all three cycles, the number of CFUs was
less than the number of CFUs detected for the unmodified control. Hojati et al. found that
in composite resin discs aged for 48 h, there was a reduction in the number of CFUs in all
the ZnO-NP composites compared to the control [19]. However, in their samples, which
were aged for 1 week and 4 weeks, no statistically significant difference in the number of
CFUs was detected between any of the ZnO-NP composites and the control [19,25]. This
is not surprising, as the use of a PBS buffer solution would have rapidly degraded the
ZnO-NP due to the known sensitivity of ZnO-NP to phosphate [35]. Agar diffusion tests
performed by Sevinç et al. and Hojati et al. did not reveal a zone of inhibition around any
of the composite samples, suggesting that there is no peripheral antibacterial effect with the
ZnO-NP composite resins due to the insolubility of the ZnO-NPs [19,25]. Taken together,
these results suggest that in a clinical situation, in which a composite resin restoration will
be exposed to the varying chemistry of the oral cavity for many years, the antibacterial
effectiveness of ZnO-NP in ZnO-NP composite resins may be negligible.
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Three of the four studies included in this review visualized their samples of bacte-
rial colonization of composite resin under a scanning electron microscope (SEM) and/or
a confocal laser scanning microscope (CLSM) [19,25,32]. Sevinç et al. found that S. so-
brinus attachment and biofilm coverage and density were all qualitatively lower on the
10 wt % ZnO-NP composites compared to unmodified control composites in both SEM and
CLSM [25]. Hojati et al. observed that in samples aged for either 1 h or 24 h, there was a
qualitatively lower number of and smaller bacterial colonies in composite resins containing
higher concentration of ZnO-NPs (3, 4 and 5 wt %) compared to the composite resins
containing a lower concentration of ZnO-NPs (0, 1, and 2 wt %) under the SEM [19]. Finally,
Brandão et al. noted a decrease in the number of colonies in the 1, 2, 5, and 10 wt % ZnO-NP
composites compared to control under the SEM, indicating a significant improvement in
antibacterial effectiveness as the ZnO-NP concentration increased [32]. Nevertheless, the
results of this image analysis should be interpreted with caution, as there is a high risk of
bias in sample selection, image selection, and interpretation of SEM or CLSM images by all
three studies [19,25,32].
In addition to the above-mentioned tests, two of the studies performed tests unique to
their respective studies [25,32]. These included the kinetic measurement of bacterial growth
test by Sevinç et al., and the metabolic activity assay (MTT) and lactic acid production tests
by Brandão et al. [25,32]. In the kinetic measurement of bacterial growth test, it was noted
that 1, 5, and 10 wt % ZnO-NP composites showed a reduction in absorbance measurements
compared to the positive control and hence improved the antibacterial activity against
planktonic cultures of S. sobrinus; no statistically significant difference was found between
these composites [25]. In the metabolic activity assay, it was found that the 1, 2, 5, and
10 wt % ZnO-NP composites decreased the metabolic activity of the S. mutans biofilm
compared to the control. The 0.5 wt % ZnO-NP composite did not show a statistically
significant difference compared to the control [32]. Finally, in the lactic acid production test,
only the 5 and 10 wt % ZnO-NP composites reduced the production of lactic acid by the
S. mutans biofilm [32]. This suggests that with low-concentration ZnO-NP composite resins
that are required for mechanical stability clinically, there will be little effect on secondary
caries prevention, as at low wt % ZnO, there is insufficient inhibition of the formation of
lactic acid, which causes tooth demineralization.
Two of the studies included in this review also assessed changes in the mechanical and
physiochemical properties of the composite resins as a result of the addition of ZnO-NP
into the resin matrix. Hojati et al. concluded that the addition of up to 1 wt % ZnO-NPs into
composite resins does not adversely affect the mechanical properties of the composite [19].
No adverse effects due to the addition of the ZnO-NP on the degree of conversion, flexural
strength, compressive strength, and bond strength were found. However, they noted that
as ZnO-NP concentrations increase, the depth of cure decreased significantly, finding that
composite resins containing 5 wt % ZnO-NP had half the depth of cure of the unmodified
control group [19]. Brandão et al. found that for 2–5 wt % ZnO-NP composite resins,
there were no adverse effects on degree of conversion, flexural strength, elastic modulus,
water sorption, and water solubility [32]. However, they found that microhardness and
translucency were negatively affected by the addition of ZnO-NPs to the resin matrix of
dental composites above 1% wt % [32].
The studies included in this systematic review display three primary limitations; study
design, short term evaluation of antibacterial activity, and limited bacterial species against
which the antibacterial effects were evaluated. All the studies included in this review are
in vitro studies; therefore, the results may not translate to clinically relevant conclusions.
Conditions in an oral cavity differ substantially from the in vitro conditions used in the
included studies. The biochemical nature of the oral cavity is constantly changing as it is
being flushed with saliva, food, and fluid drinks. This dynamic chemical environment has
the potential to alter the results/conclusions drawn from these studies of the antibacterial
agents in dental composites in controlled in vitro settings [36]. Furthermore, none of the
studies had any operator blinding, potentially leading to bias in the interpretation of
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data, especially in tests where subjective interpretation was required, such as the scanning
electron microscopy and confocal laser scanning microscopy.
Most of the tests used to assess antibacterial activity were short-term (1–3 days). Long-
term studies of the antibacterial effect of ZnO-NP are yet to be conducted. A short-term
exposure of zinc nanoparticle incorporated composite against bacteria does not represent
how well the restorations will perform in the oral cavity over an extended period of time.
Around 60% of composite resin restorations are expected to last for more than 10 years, if
sound restorative principles and techniques are employed during placement [8]. Therefore,
a long-term study of ZnO-NP dental composites in vivo is required to provide a more
definitive answer as to the efficacy of ZnO-NP as antibacterial agents in restorations in the
oral cavity. This would only be warranted once ZnO-NP composites are developed that
clearly demonstrate long-term (>1 week) anti-microbial activity in in vitro tests, as this has
yet to be established.
Finally, most of the studies included in this review used single species biofilms to
test the antibacterial activity of ZnO-NP dental composites except for Sevinç et al., who
used a three-species biofilm for a single test, and in this test, they found no statistically
significant difference between the ZnO-NP composites compared to the control [25]. Due
to the symbiotic activity of oral biofilms, testing against a wide range of oral species for an
extended period may yield results that are more relevant to a clinical situation [34].
5. Conclusions
There is a lack of congruity in the data from these studies due to the variation in
assessment methods used to evaluate the antibacterial activity of ZnO-NP direct dental
composite resins. Some tests such as the single species direct contact tests, metabolic assay
tests, and visualization under electron microscopy demonstrated a significant improvement
of antibacterial properties in composites containing at least 1 or 2 wt % ZnO-NPs compared
to controls. Other tests such as aged direct contact test, multi-species direct contact tests,
and the lactic acid production test showed little to no difference compared to the controls,
particularly at lower ZnO-NP concentrations, or over extended periods of time. Current
evidence suggests that ZnO-NP composites are unlikely to present any clear clinical advan-
tage due to the short lifetime of observed anti-bacterial properties, and the poor results
against multi-species biofilms in the in vitro studies examined in this systematic review.
Further research is warranted in developing ZnO-NP with enhanced long-term bioactivity
and enhanced antibacterial efficacy against multi-species biofilms. Efforts to improve and
develop standardized study designs to mimic the oral environment in vivo and methods
for the optimization of materials including the ZnO-NP are paramount.
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